Richard Margolin
Directeur/Membre du Conseil chez REVIVA PHARMACEUTICALS HOLDINGS, INC.
Fortune : - $ au 30/06/2024
Profil
Richard A.
Margolin is the founder of CNS Research, Inc. (founded in 2018).
He is currently an Independent Director at Reviva Pharmaceuticals Holdings, Inc. (since 2020), Chief Medical Officer at Eikonizo Therapeutics, Inc. (since 2020), and SVP-Translational Sciences & Clinical Development at TauC3 Biologics Ltd.
(since 2020).
Previously, he worked as an Executive Director-Internal Medicine Research Unit at Pfizer Inc. (2016-2018) and as a Vice President-Clinical Development at Cerespir, Inc. (2013-2016).
Dr. Margolin holds a doctorate degree from the University of California, Irvine and an undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/03/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Richard Margolin
| Sociétés | Poste | Début |
|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 14/12/2020 |
TAUC3 Biologics Ltd.
 TAUC3 Biologics Ltd. BiotechnologyHealth Technology TAUC3 Biologics Ltd. is engaged in the biotechnology industry. The company was founded on July19, 2019 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/02/2020 |
Eikonizo Therapeutics, Inc.
 Eikonizo Therapeutics, Inc. Medical/Nursing ServicesHealth Services Eikonizo Therapeutics, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Beverly, MA. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Anciens postes connus de Richard Margolin
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/04/2018 |
Cerespir, Inc.
 Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/12/2016 |
CNS Research, Inc.
 CNS Research, Inc. Internet Software/ServicesTechnology Services CNS Research, Inc. operates online websites that provide neurologists and medication services through research with pharmaceutical companies. The private company is based in East Providence, RI and was founded by Richard A. Margolin. | Fondateur | - |
Formation de Richard Margolin
| University of California, Irvine | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Cerespir, Inc.
Cerespir, Inc. Pharmaceuticals: MajorHealth Technology Cerespir, Inc. operates as pharmaceutical company. It develops molecules for the treatment of Alzheimer disease. The company was founded by Daniel G. Chain in November 2013 and is headquartered in New York, NY. | Health Technology |
Eikonizo Therapeutics, Inc.
Eikonizo Therapeutics, Inc. Medical/Nursing ServicesHealth Services Eikonizo Therapeutics, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Beverly, MA. | Health Services |
TAUC3 Biologics Ltd.
TAUC3 Biologics Ltd. BiotechnologyHealth Technology TAUC3 Biologics Ltd. is engaged in the biotechnology industry. The company was founded on July19, 2019 and is headquartered in London, the United Kingdom. | Health Technology |
CNS Research, Inc.
CNS Research, Inc. Internet Software/ServicesTechnology Services CNS Research, Inc. operates online websites that provide neurologists and medication services through research with pharmaceutical companies. The private company is based in East Providence, RI and was founded by Richard A. Margolin. | Technology Services |
